| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | TDRD9 DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 ATP1A1 ATP1A3 TOR3A POLQ | 1.94e-04 | 441 | 134 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.62e-04 | 196 | 134 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TDRD9 APTX DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 PPA2 GNL2 ATP1A1 ATP1A3 TOR3A ATL2 POLQ | 5.16e-04 | 839 | 134 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TDRD9 APTX DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 PPA2 GNL2 ATP1A1 ATP1A3 TOR3A ATL2 POLQ | 5.23e-04 | 840 | 134 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TDRD9 APTX DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 PPA2 GNL2 ATP1A1 ATP1A3 TOR3A ATL2 POLQ | 5.23e-04 | 840 | 134 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | lipid transfer activity | 5.82e-04 | 57 | 134 | 4 | GO:0120013 | |
| GeneOntologyMolecularFunction | phospholipid transfer activity | 6.86e-04 | 26 | 134 | 3 | GO:0120014 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 7.38e-04 | 288 | 134 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 8.44e-04 | 109 | 134 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 8.56e-04 | 28 | 134 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | TDRD9 MYO1B DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 ATP1A1 ATP1A3 TOR3A POLQ | 8.93e-04 | 614 | 134 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ceramide 1-phosphate transfer activity | 9.18e-04 | 7 | 134 | 2 | GO:1902388 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 9.18e-04 | 7 | 134 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | ceramide transfer activity | 1.22e-03 | 8 | 134 | 2 | GO:0120017 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 5.05e-06 | 6 | 132 | 3 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 5.05e-06 | 6 | 132 | 3 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 5.05e-06 | 6 | 132 | 3 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 5.05e-06 | 6 | 132 | 3 | GO:0018103 | |
| GeneOntologyBiologicalProcess | habituation | 1.40e-05 | 8 | 132 | 3 | GO:0046959 | |
| GeneOntologyBiologicalProcess | nonassociative learning | 6.99e-05 | 13 | 132 | 3 | GO:0046958 | |
| GeneOntologyBiologicalProcess | response to environmental enrichment | 1.21e-04 | 3 | 132 | 2 | GO:0090648 | |
| Domain | ARM-type_fold | USP34 GBF1 APOB HUWE1 TRRAP RYR3 NF1 UTP20 CAB39L NUP188 EIF4G3 | 2.55e-05 | 339 | 130 | 11 | IPR016024 |
| Domain | Vitellinogen_b-sht_N | 4.81e-05 | 2 | 130 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 4.81e-05 | 2 | 130 | 2 | IPR015819 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 4.81e-05 | 2 | 130 | 2 | PS51211 | |
| Domain | LPD_N | 4.81e-05 | 2 | 130 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 4.81e-05 | 2 | 130 | 2 | IPR001747 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 4.81e-05 | 2 | 130 | 2 | PF01347 | |
| Domain | ABC_A | 6.92e-05 | 12 | 130 | 3 | IPR026082 | |
| Domain | Vitellinogen_superhlx | 1.44e-04 | 3 | 130 | 2 | IPR011030 | |
| Domain | FAS1 | 2.86e-04 | 4 | 130 | 2 | SM00554 | |
| Domain | FAS1_domain | 2.86e-04 | 4 | 130 | 2 | IPR000782 | |
| Domain | Dpy19 | 2.86e-04 | 4 | 130 | 2 | PF10034 | |
| Domain | Dpy-19/Dpy-19-like | 2.86e-04 | 4 | 130 | 2 | IPR018732 | |
| Domain | - | 2.86e-04 | 4 | 130 | 2 | 2.30.180.10 | |
| Domain | FAS1 | 2.86e-04 | 4 | 130 | 2 | PS50213 | |
| Domain | Fasciclin | 2.86e-04 | 4 | 130 | 2 | PF02469 | |
| Domain | P-type_ATPase_IIC | 7.08e-04 | 6 | 130 | 2 | IPR005775 | |
| Domain | USP_CS | 1.16e-03 | 66 | 130 | 4 | IPR018200 | |
| Domain | USP_1 | 1.44e-03 | 70 | 130 | 4 | PS00972 | |
| Domain | UCH | 1.52e-03 | 71 | 130 | 4 | PF00443 | |
| Domain | USP_2 | 1.52e-03 | 71 | 130 | 4 | PS00973 | |
| Domain | USP_3 | 1.60e-03 | 72 | 130 | 4 | PS50235 | |
| Domain | USP_dom | 1.60e-03 | 72 | 130 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.60e-03 | 72 | 130 | 4 | IPR001394 | |
| Domain | AAA | 3.36e-03 | 144 | 130 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 3.36e-03 | 144 | 130 | 5 | IPR003593 | |
| Domain | ConA-like_dom | 4.34e-03 | 219 | 130 | 6 | IPR013320 | |
| Domain | ABC_tran | 4.53e-03 | 48 | 130 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.53e-03 | 48 | 130 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.81e-03 | 49 | 130 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 5.09e-03 | 50 | 130 | 3 | IPR003439 | |
| Domain | ATPase_P-typ_TM_dom | 5.41e-03 | 16 | 130 | 2 | IPR023298 | |
| Domain | - | 5.41e-03 | 16 | 130 | 2 | 1.20.1110.10 | |
| Domain | - | ADCY10 TDRD9 DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 GNL2 TOR3A ATL2 POLQ | 5.89e-03 | 746 | 130 | 12 | 3.40.50.300 |
| Domain | Poly(ADP-ribose)pol_cat_dom | 6.11e-03 | 17 | 130 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 6.11e-03 | 17 | 130 | 2 | PS51059 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.11e-03 | 17 | 130 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.11e-03 | 17 | 130 | 2 | PF00689 | |
| Domain | PARP | 6.11e-03 | 17 | 130 | 2 | PF00644 | |
| Domain | - | 6.11e-03 | 17 | 130 | 2 | 3.90.228.10 | |
| Domain | P-loop_NTPase | ADCY10 TDRD9 MYO1B DNAH7 ABCA10 ABCA9 RUVBL1 ABCA5 SMC3 GNL2 TOR3A ATL2 POLQ | 6.23e-03 | 848 | 130 | 13 | IPR027417 |
| Domain | Cation_ATPase_N | 6.84e-03 | 18 | 130 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 6.84e-03 | 18 | 130 | 2 | SM00831 | |
| Pubmed | USP34 SRRM1 ZC3H14 MAP1B NSD1 MYO1B HUWE1 TRRAP PBRM1 NF1 PHF3 GNL2 UTP20 NUP188 ATP1A1 EIF4G3 HDAC2 | 7.55e-10 | 653 | 135 | 17 | 22586326 | |
| Pubmed | 1.21e-08 | 20 | 135 | 5 | 22028030 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 USP34 GBF1 DPY19L1 C6orf89 GDE1 CCNT2 PARP1 NAA25 CYFIP1 PBRM1 LMAN2L PHF3 UGT8 UQCC1 NUP188 ATP1A1 ATL2 GNPAT | 2.21e-07 | 1203 | 135 | 19 | 29180619 |
| Pubmed | ZC3H14 TES MAP1B NSD1 HUWE1 TRRAP BRAP CYFIP1 RUVBL1 PHF3 STEEP1 USP15 HDAC2 | 2.49e-07 | 549 | 135 | 13 | 38280479 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TES MAP1B HUWE1 TRRAP CYFIP1 STXBP1 RUVBL1 SMC3 CCDC47 UTP20 NUP188 ATP1A1 DCTN4 EIF4G3 | 6.84e-07 | 704 | 135 | 14 | 29955894 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | USP34 SRRM1 GBF1 APOB DNAH7 PARP1 NF1 STYX KIAA1217 ATP1A1 ALK | 8.19e-07 | 420 | 135 | 11 | 28065597 |
| Pubmed | SRRM1 DNAJC19 ICE2 SPG11 TRRAP TSEN2 CCNT2 PARP1 SERPINB6 PBRM1 NF1 SMC3 FBXO42 STEEP1 UQCC1 NUP188 ATP1A3 ATL2 PPTC7 | 9.64e-07 | 1327 | 135 | 19 | 32694731 | |
| Pubmed | 1.86e-06 | 285 | 135 | 9 | 32838362 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SRRM1 ZC3H14 MAP1B MYO1B HUWE1 TRRAP PARP1 PBRM1 NF1 RUVBL1 SMC3 GNL2 UTP20 NUP188 ATP1A1 HDAC2 | 2.48e-06 | 1024 | 135 | 16 | 24711643 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SRRM1 GBF1 MYO1B RAB11FIP1 TRRAP USP8 NAA25 RUVBL1 SMC3 CCDC47 STEEP1 GNL2 CAB39L NUP188 EIF4G3 POLQ USP15 MOB4 | 2.57e-06 | 1284 | 135 | 18 | 17353931 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 SRRM1 RIPK1 UACA MAP1B DPY19L1 MYO1B TRRAP CCNT2 CYFIP1 CCDC198 NF1 NUP188 DCTN4 HDAC2 | 2.74e-06 | 910 | 135 | 15 | 36736316 |
| Pubmed | SRRM1 MAP1B PARP8 MYO1B SPG11 APOB DCC NEB USP8 PARP1 STXBP1 CCDC47 MTTP UGGT2 ATP1A1 ATP1A3 EIF4G3 POLQ HDAC2 | 3.25e-06 | 1442 | 135 | 19 | 35575683 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 FAT4 MAP1B DPY19L1 LAMA4 GDE1 LMAN2L NF1 RUVBL1 CCDC47 UGT8 UTP20 UGGT2 ATP1A1 TOR3A EIF4G3 USP15 | 4.40e-06 | 1201 | 135 | 17 | 35696571 |
| Pubmed | 5.39e-06 | 244 | 135 | 8 | 28902428 | ||
| Pubmed | SHANK1 UACA SH3GL2 NSD1 HUWE1 PARP1 CYFIP1 PBRM1 NF1 KCNB1 KIAA1217 DGKI PLCL1 MOB4 HDAC2 | 5.42e-06 | 963 | 135 | 15 | 28671696 | |
| Pubmed | USP34 TES ICE2 SPG11 HUWE1 BRAP USP8 CCDC47 PHF3 GNL2 UGGT2 ATL2 USP15 | 6.04e-06 | 733 | 135 | 13 | 34672954 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 6.73e-06 | 10 | 135 | 3 | 11435397 | |
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 17478428 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 GBF1 MAP1B EXPH5 PARP8 RAB11FIP1 DNAH7 USP8 NF1 PHF3 KIAA1217 CRYBG3 EIF4G3 PIBF1 | 7.01e-06 | 861 | 135 | 14 | 36931259 |
| Pubmed | 8.15e-06 | 121 | 135 | 6 | 22412018 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TES RIPK1 UACA DNAJC19 USP25 LMAN2L PRIM1 GNL2 UTP20 UGGT2 UQCC1 PIBF1 HDAC2 | 8.17e-06 | 754 | 135 | 13 | 33060197 |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 8.67e-06 | 71 | 135 | 5 | 28319113 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.15e-06 | 440 | 135 | 10 | 34244565 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 MYO1B APOB HUWE1 PARP1 CYFIP1 PBRM1 NF1 RUVBL1 SMC3 CCDC47 PRIM1 PPA2 GNL2 UTP20 NUP188 ATP1A1 ATL2 | 1.07e-05 | 1425 | 135 | 18 | 30948266 |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24179170 | ||
| Pubmed | Human placenta secretes apolipoprotein B-100-containing lipoproteins. | 1.50e-05 | 2 | 135 | 2 | 15504742 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 3035575 | ||
| Pubmed | Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). | 1.50e-05 | 2 | 135 | 2 | 3498943 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 1534146 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15795421 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 1.50e-05 | 2 | 135 | 2 | 7889415 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 1.50e-05 | 2 | 135 | 2 | 11546672 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 3025647 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28057529 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2452747 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9233619 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24391932 | ||
| Pubmed | Stalk region of beta-chain enhances the coreceptor function of CD8. | 1.50e-05 | 2 | 135 | 2 | 12847256 | |
| Pubmed | A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. | 1.50e-05 | 2 | 135 | 2 | 10713055 | |
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 1.50e-05 | 2 | 135 | 2 | 23761886 | |
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 1.50e-05 | 2 | 135 | 2 | 8436166 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24842304 | ||
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 1.50e-05 | 2 | 135 | 2 | 3030810 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 3169881 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11358959 | ||
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 1.50e-05 | 2 | 135 | 2 | 7103930 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 25354700 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 25354701 | ||
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 1.50e-05 | 2 | 135 | 2 | 5558567 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27487388 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12034498 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19056372 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21498719 | ||
| Pubmed | Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining. | 1.50e-05 | 2 | 135 | 2 | 33911081 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28993228 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28702990 | ||
| Pubmed | ALK upregulates POSTN and WNT signaling to drive neuroblastoma. | 1.50e-05 | 2 | 135 | 2 | 38451815 | |
| Pubmed | Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. | 1.50e-05 | 2 | 135 | 2 | 8108731 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21460625 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9915855 | ||
| Pubmed | Murine Ly-3 restriction fragment length polymorphism and transcript size differences. | 1.50e-05 | 2 | 135 | 2 | 2576243 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28629962 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22764053 | ||
| Pubmed | The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. | 1.50e-05 | 2 | 135 | 2 | 9647223 | |
| Pubmed | Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia. | 1.50e-05 | 2 | 135 | 2 | 18027103 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 408079 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 14732481 | ||
| Pubmed | Characterization of the mouse CD8 beta chain-encoding gene promoter region. | 1.50e-05 | 2 | 135 | 2 | 8781121 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 35688666 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17690102 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 GBF1 DPY19L2 SPG11 APOB HUWE1 USP8 LMAN2L NF1 PPA2 UGGT2 NUP188 ATL2 MOB4 GNPAT | 1.70e-05 | 1061 | 135 | 15 | 33845483 |
| Pubmed | ADCY10 USP34 MAP1B ICE2 SPG11 HUWE1 TRRAP PARP1 RUVBL1 SMC3 PRIM1 PPA2 STEEP1 NUP188 ATP1A1 USP15 HDAC2 | 1.73e-05 | 1335 | 135 | 17 | 29229926 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.03e-05 | 212 | 135 | 7 | 33853758 | |
| Pubmed | RIPK1 MAP1B ICE2 MYO1B PARP1 CYFIP1 RUVBL1 SMC3 CCDC47 CRYBG3 ATP1A1 EIF4G3 | 2.18e-05 | 708 | 135 | 12 | 39231216 | |
| Pubmed | 2.22e-05 | 215 | 135 | 7 | 30462309 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 2.40e-05 | 392 | 135 | 9 | 33144569 | |
| Pubmed | 2.47e-05 | 147 | 135 | 6 | 29576527 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.60e-05 | 497 | 135 | 10 | 36774506 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.64e-05 | 221 | 135 | 7 | 29991511 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 NSD1 TRRAP LIN9 PARP1 PBRM1 SMC3 PHF3 STEEP1 GNL2 HDAC2 | 2.70e-05 | 608 | 135 | 11 | 36089195 |
| Pubmed | 2.76e-05 | 399 | 135 | 9 | 37536630 | ||
| Pubmed | SRRM1 ZC3H14 MYO1B TRRAP CYFIP1 PBRM1 RUVBL1 SMC3 PHF3 GNL2 UTP20 PLD1 DCTN4 | 2.76e-05 | 847 | 135 | 13 | 35850772 | |
| Pubmed | SRRM1 ZC3H14 UACA MYO1B HUWE1 BRAP CCNT2 PARP1 CYFIP1 RUVBL1 SMC3 PHF3 ATP1A1 ATP1A3 USP15 HDAC2 | 2.85e-05 | 1247 | 135 | 16 | 27684187 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TES SH3GL2 CNTLN DNAH7 RUVBL1 NANS KIAA1217 PRIM1 SLC25A15 ATP1A1 DCTN4 PIBF1 USP15 | 2.97e-05 | 853 | 135 | 13 | 28718761 |
| Pubmed | SHANK1 MAP1B SH3GL2 HUWE1 SERPINB6 NF1 STXBP1 RUVBL1 KCNB1 KIAA1217 PPA2 CRYBG3 EIF4G3 USP15 HDAC2 | 3.84e-05 | 1139 | 135 | 15 | 36417873 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MAP1B USP25 HUWE1 TRRAP USP8 PARP1 SMC3 PRIM1 GNL2 UGGT2 NUP188 EIF4G3 USP15 MOB4 | 3.87e-05 | 1005 | 135 | 14 | 19615732 |
| Pubmed | USP34 SRRM1 ZC3H14 TRRAP CCNT2 PARP1 PBRM1 SMC3 NANS PHF3 PRIM1 STEEP1 MAGEC2 HDAC2 | 4.26e-05 | 1014 | 135 | 14 | 32416067 | |
| Pubmed | RIPK1 EXPH5 AOAH LAMA4 NEB DNAH7 EVI5 POSTN SERPINB6 NF1 UGT8 PLCL1 POLQ MAGEC2 HDAC2 TMEM234 | 4.40e-05 | 1293 | 135 | 16 | 15342556 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 2822726 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 11727199 | ||
| Pubmed | Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2 for Ly-3 surface expression. | 4.48e-05 | 3 | 135 | 2 | 3258885 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 3378837 | ||
| Pubmed | Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus. | 4.48e-05 | 3 | 135 | 2 | 100557 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23042941 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 9218488 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 4.48e-05 | 3 | 135 | 2 | 26373354 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19026012 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17947306 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12810689 | ||
| Interaction | EPHA1 interactions | 3.46e-06 | 235 | 132 | 10 | int:EPHA1 | |
| Interaction | SIRT7 interactions | USP34 SRRM1 ZC3H14 MAP1B NSD1 MYO1B HUWE1 TRRAP PBRM1 NF1 PHF3 GNL2 UTP20 NUP188 ATP1A1 EIF4G3 HDAC2 | 7.46e-06 | 744 | 132 | 17 | int:SIRT7 |
| Interaction | MYH9 interactions | GBF1 UACA MAP1B USP25 MYO1B APOB HUWE1 TRRAP CYFIP1 RUVBL1 PHF3 SPATA16 ATP1A1 USP15 CCDC180 ALK HDAC2 | 8.87e-06 | 754 | 132 | 17 | int:MYH9 |
| Interaction | C5AR2 interactions | 1.23e-05 | 78 | 132 | 6 | int:C5AR2 | |
| Interaction | MECOM interactions | MAP1B MYO1B NEB PARP1 CYFIP1 RUVBL1 SMC3 GNL2 ATP1A1 CCDC180 HDAC2 | 2.43e-05 | 358 | 132 | 11 | int:MECOM |
| Interaction | AR interactions | USP34 EXPH5 NSD1 MYO1B HUWE1 DCC RAB11FIP1 TRRAP LIN9 PARP1 CYFIP1 PBRM1 RUVBL1 SMC3 PHF3 KIAA1217 NUP188 VAV2 HDAC2 | 2.52e-05 | 992 | 132 | 19 | int:AR |
| Interaction | TNFRSF8 interactions | 4.82e-05 | 31 | 132 | 4 | int:TNFRSF8 | |
| Interaction | KCNA3 interactions | ADCY10 SRRM1 RIPK1 MAP1B EXPH5 ICE2 MYO1B PARP1 CYFIP1 RUVBL1 SMC3 CCDC47 PHF3 CRYBG3 ATP1A1 EIF4G3 POLQ | 5.54e-05 | 871 | 132 | 17 | int:KCNA3 |
| Interaction | MYOF interactions | 5.67e-05 | 102 | 132 | 6 | int:MYOF | |
| Interaction | USP15 interactions | GBF1 RIPK1 HUWE1 BRAP USP8 PARP1 RUVBL1 KCNB1 SMC3 DCTN4 PIBF1 USP15 HDAC2 | 6.25e-05 | 546 | 132 | 13 | int:USP15 |
| Interaction | MILR1 interactions | 7.25e-05 | 66 | 132 | 5 | int:MILR1 | |
| Interaction | USP8 interactions | 7.64e-05 | 156 | 132 | 7 | int:USP8 | |
| GeneFamily | ATP binding cassette subfamily A | 3.16e-05 | 14 | 82 | 3 | 805 | |
| GeneFamily | Ubiquitin specific peptidases | 1.21e-04 | 56 | 82 | 4 | 366 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 4.20e-04 | 7 | 82 | 2 | 1208 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 ZC3H14 GBF1 MAP1B MYO1B SPG11 TRRAP EVI5 ZFYVE9 SMC3 PHF3 UTP20 CRYBG3 EIF4G3 PIBF1 USP15 MOB4 | 1.66e-06 | 856 | 133 | 17 | M4500 |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | STAB2 DPY19L2 LAMA4 POSTN ST8SIA6 SLC14A1 SCNN1G DGKI PLCL1 ALK | 2.46e-10 | 183 | 135 | 10 | ba43bca2b45be1008eebd3f033cecb061fb3a966 |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 2.41e-08 | 154 | 135 | 8 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.56e-08 | 184 | 135 | 8 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-07 | 189 | 135 | 8 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-07 | 190 | 135 | 8 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 195 | 135 | 8 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-07 | 196 | 135 | 8 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.63e-07 | 166 | 135 | 7 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.27e-07 | 168 | 135 | 7 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-06 | 180 | 135 | 7 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 181 | 135 | 7 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 181 | 135 | 7 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 181 | 135 | 7 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 181 | 135 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 181 | 135 | 7 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 183 | 135 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 184 | 135 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 184 | 135 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 184 | 135 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-06 | 187 | 135 | 7 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 194 | 135 | 7 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-06 | 196 | 135 | 7 | a4cc02ea41479d24044bd2ca6441f85d683c0ca9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-06 | 198 | 135 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-06 | 198 | 135 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.64e-06 | 200 | 135 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-06 | 158 | 135 | 6 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 162 | 135 | 6 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-05 | 165 | 135 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-05 | 168 | 135 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 169 | 135 | 6 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 171 | 135 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 171 | 135 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-05 | 172 | 135 | 6 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-05 | 172 | 135 | 6 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 174 | 135 | 6 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 175 | 135 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-05 | 175 | 135 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 177 | 135 | 6 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 177 | 135 | 6 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 177 | 135 | 6 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-05 | 177 | 135 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-05 | 177 | 135 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 177 | 135 | 6 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 180 | 135 | 6 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 181 | 135 | 6 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 186 | 135 | 6 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.29e-05 | 187 | 135 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 189 | 135 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 190 | 135 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 190 | 135 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-05 | 191 | 135 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 192 | 135 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 192 | 135 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.74e-05 | 193 | 135 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.74e-05 | 193 | 135 | 6 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.82e-05 | 194 | 135 | 6 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 194 | 135 | 6 | fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 194 | 135 | 6 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-05 | 195 | 135 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 195 | 135 | 6 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 195 | 135 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 196 | 135 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 2.98e-05 | 196 | 135 | 6 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.98e-05 | 196 | 135 | 6 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.98e-05 | 196 | 135 | 6 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.07e-05 | 197 | 135 | 6 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 197 | 135 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-05 | 197 | 135 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-05 | 197 | 135 | 6 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.16e-05 | 198 | 135 | 6 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-05 | 198 | 135 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.16e-05 | 198 | 135 | 6 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.16e-05 | 198 | 135 | 6 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 199 | 135 | 6 | 527aae1d9d37a50deefc01fc0c064a53673681bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.34e-05 | 200 | 135 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 7.04e-05 | 141 | 135 | 5 | 7cbe8abdd004430d58ce31e0b613894a4cf6726e | |
| ToppCell | Adult-Immune-mast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 157 | 135 | 5 | 4c63bb91f8708644e6ce2500072a4eeb8e1079dd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 160 | 135 | 5 | 86fde32f096eaf9ea3677f57169cdcc0a57bb8dd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 163 | 135 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 163 | 135 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 163 | 135 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 166 | 135 | 5 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 166 | 135 | 5 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 166 | 135 | 5 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.56e-04 | 167 | 135 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | 53e32d6687a07f486141df9f4ab998af4c03a507 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-04 | 169 | 135 | 5 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 170 | 135 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.69e-04 | 170 | 135 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.69e-04 | 170 | 135 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.69e-04 | 170 | 135 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 173 | 135 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.84e-04 | 173 | 135 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-04 | 173 | 135 | 5 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| Disease | Colorectal Carcinoma | SHANK1 MAP1B PARP8 MYO1B APOB DCC ABCA10 ABCA9 POSTN PARP1 NF1 ABCA5 LRRC3B SCNN1G | 3.38e-06 | 702 | 132 | 14 | C0009402 |
| Disease | Intellectual Disability | ZC3H14 MAP1B NSD1 DCC TRRAP TSEN2 PARP1 LMAN2L NF1 CCDC47 ATP1A1 | 5.71e-06 | 447 | 132 | 11 | C3714756 |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 8.76e-06 | 62 | 132 | 5 | EFO_0004616, EFO_1000786 | |
| Disease | melanoma | 1.67e-05 | 248 | 132 | 8 | C0025202 | |
| Disease | epilepsy | 3.41e-05 | 41 | 132 | 4 | EFO_0000474 | |
| Disease | neuroligin-1 measurement | 5.94e-05 | 3 | 132 | 2 | EFO_0802802 | |
| Disease | periostin measurement | 1.18e-04 | 4 | 132 | 2 | EFO_0020628 | |
| Disease | Flushing | 1.18e-04 | 4 | 132 | 2 | HP_0031284 | |
| Disease | Schizophrenia | SHANK1 DCC TRRAP BRAP CFAP65 CYFIP1 PBRM1 LMAN2L STXBP1 KCNB1 ALK HDAC2 GNPAT | 1.72e-04 | 883 | 132 | 13 | C0036341 |
| Disease | factor VIII measurement, coagulation factor measurement | 1.97e-04 | 5 | 132 | 2 | EFO_0004630, EFO_0004634 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.53e-04 | 195 | 132 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 2.59e-04 | 277 | 132 | 7 | C0009404 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.90e-04 | 200 | 132 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | coffee consumption | 3.95e-04 | 32 | 132 | 3 | EFO_0004330 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 4.11e-04 | 7 | 132 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | fornix volume measurement | 4.11e-04 | 7 | 132 | 2 | EFO_0803381 | |
| Disease | Profound Mental Retardation | 4.13e-04 | 139 | 132 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.13e-04 | 139 | 132 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.13e-04 | 139 | 132 | 5 | C0917816 | |
| Disease | alcohol use disorder measurement | 4.16e-04 | 214 | 132 | 6 | EFO_0009458 | |
| Disease | carbohydrate intake measurement | 4.73e-04 | 34 | 132 | 3 | EFO_0010811 | |
| Disease | osteoarthritis, spine, body mass index | 5.46e-04 | 8 | 132 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | epilepsy (is_implicated_in) | 7.00e-04 | 9 | 132 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | Pulmonary Cystic Fibrosis | 7.00e-04 | 9 | 132 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 7.00e-04 | 9 | 132 | 2 | C1527396 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 7.26e-04 | 90 | 132 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Inherited neuropathies | 7.66e-04 | 40 | 132 | 3 | C0598589 | |
| Disease | Cutaneous Melanoma | 8.24e-04 | 41 | 132 | 3 | C0151779 | |
| Disease | Tetralogy of Fallot | 8.73e-04 | 10 | 132 | 2 | HP_0001636 | |
| Disease | platelet glycoprotein ib alpha chain measurement | 8.73e-04 | 10 | 132 | 2 | EFO_0020645 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 8.73e-04 | 10 | 132 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Adenocarcinoma of large intestine | 9.25e-04 | 96 | 132 | 4 | C1319315 | |
| Disease | forced expiratory volume, body mass index | 1.06e-03 | 11 | 132 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Cystic Fibrosis | 1.06e-03 | 11 | 132 | 2 | C0010674 | |
| Disease | psychological resilience measurement | 1.27e-03 | 12 | 132 | 2 | EFO_0009945 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.27e-03 | 12 | 132 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | blood copper measurement | 1.47e-03 | 50 | 132 | 3 | EFO_0007578 | |
| Disease | idiopathic osteonecrosis of the femoral head | 1.65e-03 | 52 | 132 | 3 | EFO_1001930 | |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | BMI-adjusted adiponectin measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0007737 | |
| Disease | tumor necrosis factor measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0010834 | |
| Disease | pro-hydroxy-pro measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0021132 | |
| Disease | Rolandic epilepsy | 2.29e-03 | 16 | 132 | 2 | Orphanet_1945 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.66e-03 | 128 | 132 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C0007134 | |
| Disease | Child Behaviour Checklist assessment | 2.90e-03 | 18 | 132 | 2 | EFO_0005661 | |
| Disease | syndrome (implicated_via_orthology) | 2.90e-03 | 18 | 132 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Myeloid Leukemia | 2.90e-03 | 18 | 132 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.90e-03 | 18 | 132 | 2 | C0023466 | |
| Disease | hip bone size | 3.12e-03 | 65 | 132 | 3 | EFO_0004844 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.58e-03 | 20 | 132 | 2 | DOID:3328 (is_marker_for) | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 3.70e-03 | 69 | 132 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | Nonorganic psychosis | 3.70e-03 | 69 | 132 | 3 | C0349204 | |
| Disease | platelet crit | SRRM1 C6orf89 EXPH5 APOB BRAP PARP1 NAA25 SERPINB6 NF1 PRIM1 USP15 | 3.73e-03 | 952 | 132 | 11 | EFO_0007985 |
| Disease | stroke, coronary artery disease | 3.94e-03 | 21 | 132 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | Obsessive-compulsive trait | 3.94e-03 | 21 | 132 | 2 | HP_0008770 | |
| Disease | hip bone mineral density, fat body mass | 4.33e-03 | 22 | 132 | 2 | EFO_0005409, EFO_0007702 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.47e-03 | 148 | 132 | 4 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LILISMMHPNKKYEE | 46 | Q8WWZ7 | |
| TKYISKPENLKLMMN | 246 | Q9H9S4 | |
| MKIIRDSTPNQYMVL | 191 | Q7Z569 | |
| PIKMKIPIANTEKYM | 481 | O60583 | |
| PSRSMDLEMKQLQYK | 1086 | Q9NXG0 | |
| LKVEMPMNLKVIIYE | 2471 | Q68DQ2 | |
| LEMKYGNEIMNKDPV | 1136 | Q8WWZ4 | |
| MQMPQYQGRTKLVKD | 76 | Q6UX41 | |
| YLLEMKLKNLAQMEP | 1516 | Q8IUA7 | |
| SKEVNEIMVKMPYQC | 431 | Q3SY69 | |
| MVYTSRMPKLSQVNE | 4861 | Q6V0I7 | |
| KISMQDPKMQVYKDE | 186 | Q7Z2E3 | |
| LEMSLQKYVMESILK | 261 | Q96PN6 | |
| LTKEVMEYPAIMLKE | 606 | Q9P1Z9 | |
| DYIKMSINPKKLVMG | 236 | Q01459 | |
| KMTQYLENMKIGETI | 101 | Q6BCY4 | |
| IEPDYKFSTLLMMLK | 901 | Q96L73 | |
| MVEYEIDLQKMPLGK | 686 | P09874 | |
| MTTPEKLYSNVMQTL | 386 | P28039 | |
| LQYVKTLMEVMPKIC | 946 | Q7L576 | |
| CKPMQMYVLDIKDTK | 641 | Q6P3S6 | |
| KPNTMYEFSVMVTKN | 911 | P43146 | |
| KSKYMTPMQQKLNEV | 651 | Q86U86 | |
| REMTQAPYLEIKKQM | 616 | Q8N3A8 | |
| PYKVVMKQSKLPMSL | 106 | Q13823 | |
| MNTEAEKLKSYSMPI | 366 | Q5TKA1 | |
| EMYVLNPVKSSKEMQ | 421 | P46821 | |
| YQMKEPITKADMLRN | 126 | Q96LZ2 | |
| PVTEAEMLMIVIKYK | 161 | Q9UBF1 | |
| TKFMDQKNSLYLMPI | 1716 | Q6ZU64 | |
| KIMESFKNMVPQQAL | 156 | P05023 | |
| PLMNMVIYSIDKAKK | 381 | Q96A33 | |
| IMVVQEMKKYFPSER | 56 | P56645 | |
| DKMVSVLYNVITPML | 266 | P0C623 | |
| ELPQEMNKYMLAIVQ | 566 | P55157 | |
| SMPIKDQYSELLKMT | 181 | O60447 | |
| MIMNDKLTEYPLVIN | 86 | Q2PZI1 | |
| YPKELNAIMESMLNK | 256 | Q8NG66 | |
| QTATSLSKPQMIMYK | 46 | H3BRN8 | |
| QMLKQPLTYRLSKEM | 76 | Q8NEV8 | |
| MTQYIRLTPDMQSKQ | 81 | Q9H0V9 | |
| NLPKKTTDYAMLVTM | 196 | Q96PB8 | |
| FLMYMKPKSQETLNS | 256 | Q8NGS8 | |
| PSKFQKIIYMNMISV | 366 | Q6NUT2 | |
| ESLTKMYSIPKDKQM | 241 | Q7Z6Z7 | |
| LPVLEMYSKLKEQMS | 136 | Q8TAG9 | |
| FDNMPDYMILQELKK | 226 | Q8NI37 | |
| LEKEMQKMNPYKIDI | 66 | P49642 | |
| KLQSTTVMNPYMKLA | 4541 | P04114 | |
| PAYIKVQTNKMVMLS | 26 | A6NJW9 | |
| KATEALKKMYMEFPQ | 181 | Q9NZC3 | |
| VIYINSPLPQKKMTM | 321 | Q659A1 | |
| DMYNKMAKTQSQPIL | 531 | Q14721 | |
| YKMELLQIENMVLSP | 371 | O15228 | |
| EVMLLTYKSIPMQVD | 666 | O75912 | |
| PAYIKVQTNKMVMLS | 26 | P10966 | |
| DDYLVKEQLPDMQMK | 1496 | O75417 | |
| ERIMQKYNLLPEKSM | 216 | Q16880 | |
| QIVNGTMTLYKEAMK | 2151 | Q8WXX0 | |
| TMTLYKEAMKNLLPT | 2156 | Q8WXX0 | |
| RALYQKMVDKEMNPL | 271 | P57058 | |
| LAMEEIYQKPFQTLM | 226 | Q8NHH9 | |
| KIMESFKNMVPQQAL | 146 | P13637 | |
| KLMEIITVENPKMPY | 501 | Q92538 | |
| LMSLPIAKKYMSENK | 106 | Q6UWU4 | |
| ISKVMEMYQPSAVVL | 246 | Q92769 | |
| MTNQNTPEYMEKIKQ | 351 | Q92769 | |
| KQVLEKKMQTPMYTS | 131 | Q9NVL8 | |
| IMSIPNLRYMKESQV | 311 | Q9UJW0 | |
| KLHYMNIMAQVPLEK | 231 | P51170 | |
| KPRMDQYFNQMEKIV | 946 | O43432 | |
| PSKFQKIIYMNMISV | 176 | Q6ZN68 | |
| MDNEKMKIPFTDIYI | 1161 | Q16363 | |
| LYLPAMKKQMAILDA | 376 | O95397 | |
| DMKTNMPIITSKRYQ | 91 | Q8NCE0 | |
| KEMQIVDVNYLIPVM | 1461 | O75691 | |
| SENLNNEVMMKKYSP | 1201 | Q6WKZ4 | |
| IYTQKQEPPKKVMMT | 131 | Q9H5V9 | |
| ALARQYMQMLPKEKQ | 121 | Q9UGI8 | |
| MLKEKRQQSEKTFMP | 741 | Q9UQE7 | |
| MKYNLMSKDNLIVPI | 196 | Q9Y3A3 | |
| TLPAVYMAIKMSQLK | 826 | Q8NDG6 | |
| KQLEDYLTKILKMPM | 181 | Q13393 | |
| ANILEKEKMYPMALL | 526 | Q5TEA6 | |
| KNEEKPVQMMFKQST | 191 | P35237 | |
| QLTMKMLESPSVAIY | 221 | Q5T5P2 | |
| QMPKEYSQILQLHMK | 371 | P61647 | |
| SMDTMKQVYQIVKPL | 161 | Q9NR45 | |
| PLKNIMDVEMKLVYI | 116 | Q9BXB7 | |
| MEIATKEPMNPIKQY | 106 | Q9H2U2 | |
| LMIMKTVYKGPNCIE | 41 | Q13546 | |
| DLSQMLKKMPQYQKE | 326 | P61764 | |
| DTMKVKMQTFPDLYR | 31 | Q9Y619 | |
| EAIYLAKLTIQMMSP | 171 | Q8WUJ0 | |
| PSMEKKRTVYQMALN | 806 | Q9Y566 | |
| LQAMQMELQSPEYKL | 1066 | Q9UM73 | |
| PSNKDMYTEMLKSII | 161 | B2RD01 | |
| ISKKYKQHQPTDMVM | 2381 | Q96JI7 | |
| RMAKYKLMNQASPEI | 1406 | A4UGR9 | |
| IQVEMKMPAYELKIV | 226 | Q8WWB5 | |
| PDVQKKMLTAYDLMI | 961 | Q15111 | |
| ELEAKMPVIMKNSVY | 411 | A6NEE1 | |
| RKLMMKNEYIIPITS | 1621 | Q15413 | |
| AVMEIMTKTIEYLQP | 46 | Q99962 | |
| IFNQLEVKNPDSKMM | 71 | Q8IYB3 | |
| TMMIDNLKVDYLTKI | 71 | Q8WXW3 | |
| TIELMYSDKSMIQVP | 576 | Q9UHP3 | |
| VRMDPLTKPMQYKVV | 481 | Q9Y4E8 | |
| DKLITMTINEKQMYP | 1976 | P21359 | |
| MTINEKQMYPSIQAK | 1981 | P21359 | |
| MKEMKVSDIPQYSQL | 1216 | Q5SRE5 | |
| AANNMKQVKDMYLIP | 1301 | Q92576 | |
| YPNPMDKNVISVKIM | 26 | Q8N945 | |
| NEQTIMTMLQPRYSK | 516 | Q8WWQ8 | |
| GVNPYILKKNMILMT | 191 | Q9NVA1 | |
| IMTTKNSNIYKMPLS | 351 | Q13336 | |
| IRTMLYTPQEMKQII | 361 | Q9Y265 | |
| LKKMMSNQYVPVKTH | 851 | Q9BZF9 | |
| METYKHLFLEKMPQL | 1046 | Q70CQ2 | |
| IKVEVQQPMIRYMQK | 176 | P52735 | |
| QKYLIESNKQMMPLK | 291 | Q9NYU1 | |
| MSAPVYDSIKLMKDI | 321 | Q9NYU1 | |
| IAQMMVYVPKEEQLF | 366 | Q9H497 | |
| TKDLKNGMIIPSMYN | 176 | Q15063 | |
| TEPLTMEKMSNVVKY | 121 | Q9NX45 | |
| YVLQAMKHMEPQVKQ | 21 | Q96DA6 | |
| PDYIMVMVANKKSQD | 31 | Q6PJT7 | |
| LVTKYSQQMVKGMLQ | 301 | Q9Y4A5 | |
| KELYTMMTDKNISLI | 186 | P40818 | |
| MMELYEVQLHLPKFK | 281 | P48595 | |
| QEMKTLFLNTEYLMP | 46 | Q8WY98 | |
| LAMLYKISNSMLDKP | 771 | Q6ZSZ6 | |
| SIKIPSNRYNEMMKA | 1136 | O95405 | |
| IMKPLEYQFKSQIMS | 451 | Q9H808 | |
| QKQMLVDMAKKLPVY | 106 | Q96MV8 | |
| FMKMPNIVSSKDYLV | 71 | Q6ZMR3 | |
| RIVQKYFLEMKNKMP | 876 | O43795 | |
| KMQQAGMALYKIVPK | 131 | Q14CX7 | |
| VYEKNKMKIHIVPDM | 4781 | P20929 |